DOI:
10.1055/s-00000054
Pharmacopsychiatry
LinksClose Window
References
Kishi T, Mukai T, Matsuda Y. et al.
Efficacy and safety of noradrenalin reuptake inhibitor augmentation therapy for schizophrenia: A meta-analysis of double-blind randomized placebo-controlled trials.
J Psychiatr Res 2013;
47: 1557-1563
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.